IP Library Granted Patent US 10,626,429
Granted Patent B2
US 10,626,429 · App. 16/528,312 · Granted Apr 21, 2020

Methods for in vitro joining and combinatorial assembly of nucleic acid molecules

Inventors: Daniel G. Gibson (Crofton, MD); Hamilton O. Smith (San Diego, CA); Clyde A. Hutchison (La Jolla, CA); Lei Young (Gaithersburg, MD); J. Craig Venter (La Jolla, CA)
Assignee: SGI-DNA, Inc.
C12P19/34C12N9/22C12N9/93C12N15/10C12N15/1027C12N15/64C12N15/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,429
App. No.
16/528,312
Granted
Apr 21, 2020
Kind
B2
Abstract

The present invention relates to methods of joining two or more double-stranded (ds) or single-stranded (ss) DNA molecules of interest in vitro, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule of each pair share a region of sequence identity. The method allows the joining of a large number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes. It can be used, e.g., to join synthetically produced sub-fragments of a gene or genome of interest. Kits for performing the method are also disclosed. The methods of joining DNA molecules may be used to generate combinatorial libraries useful to generate, for example, optimal protein expression through codon optimization, gene optimization, and pathway optimization.

Claims (20)

1. An in vitro method of joining a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, said method comprising:

contacting in vitro the two or more DNA molecules in a single vessel with a mixture of components comprising;

(a) an isolated non-thermostable 5′ to 3′exonuclease that lacks 3′ exonuclease activity,

(b) a crowding agent selected from the group consisting of: polyethylene glycol and dextran;

(c) an isolated thermostable DNA polymerase,

(d) an isolated thermostable ligase,

(e) a mixture of dNTPs, and

(f) a suitable buffer,

under isothermal conditions and in amounts effective for joining the two or more DNA molecules to form a first assembled dsDNA molecule in a concerted reaction in said single vessel.

2. The method of claim 1 , wherein the exonuclease of (a) is a T5 exonuclease.

3. The method of claim 1 , wherein

the crowding agent of (b) is PEG, and/or

the ligase of (d) is Taq ligase.

4. The method of claim 3 wherein the crowding agent of (b) is PEG and the ligase of (d) is Taq ligase.

5. The method of claim 3 , wherein the exonuclease of (a) is a T5 exonuclease.

6. The method of claim 4 , wherein the exonuclease of (a) is a T5 exonuclease.

7. The method of claim 1 , wherein the conditions are also suitable for digesting any unpaired, non-homologous, single stranded DNAs following the joining reaction.

8. The method of claim 7 , wherein at least some of the DNA molecules to be joined comprise, at one terminus, a sequence that is non-homologous to any of the DNA molecules of interest.

9. The method of claim 8 , wherein the non-homologous sequences comprise one or more binding regions for PCR primers, and/or regions of homology to vector sequences, and/or recognition sites for one or more restriction enzymes.

10. The method of claim 1 , further comprising repeating the method to join a second set of two or more DNA molecules to one another to obtain a second assembled DNA molecule, and then joining the first and the second assembled DNA molecules to obtain a third assembled dsDNA molecule.

Assignments (6)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
Continuity (9)
Continuation 16388722 · Apr 18, 2019
Continuation 14636082 · Mar 2, 2015
Division 12371543 · Feb 13, 2009
Provisional Application 61142101 · Dec 31, 2008
Provisional Application 61098202 · Sep 18, 2008
Provisional Application 61052614 · May 12, 2008
Provisional Application 61064107 · Feb 15, 2008
Provisional Application 61029312 · Feb 15, 2008
Related Publication 20190376103A1 · Dec 12, 2019